Is there Progress? An Overview of Select Biomarker Candidates for Major Depressive Disorder

Major Depressive Disorder (MDD) contributes to a significant worldwide disease burden, expected to be second only to heart disease by 2050. However, accurate diagnosis has been a historical weakness in clinical psychiatry. As a result, there is a demand for diagnostic modalities with greater objec...

Full description

Bibliographic Details
Main Authors: Juan Joseph Young, Tim eSilber, Davide eBruno, Isaac Robert Galatzer-Levy, Nunzio ePomara, Charles Raymond Marmar
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-04-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fpsyt.2016.00072/full

Similar Items